WalIlStBuyDip

$ONDS is a highly misunderstood stock. You’re not just buying shares—you’re investing in an entire architecture known as a System of Systems. It takes months to fully grasp, but once you do, you won’t want to leave. Averaging down becomes second nature. You’ve already built your position; there’s nothing left to prove. You’re still in a strong, favorable spot. If only institutions held the stock and retail investors were absent, there would be broad consensus that ONDS competes on the same field as Palantir, Anduril, and private companies like Shield AI. They’ve been building this organically for more than a decade. We’ve accelerated the same vision through acquisitions over the past two years. Those acquisitions are already validated by hard revenue from contracts that more than cover their costs. The window is opening now into a new paradigm. We’re the smaller player delivering big-cap-level innovation—so much so that even legacy leaders like Palantir have entered into two ongoing strategic collaborations with us.

After half a year, $ASTS broke the 0.618 fib level When price reached our $52 target, we thought it might be near a bottom However, the recent sell-off put price into the middle of our range While $ASTS dropped, the business has continued to develop What could the initial revenue opportunity look like if $ASTS deploys their worldwide constellation?

$RZLV Here’s a rephrased version with the same meaning:Although Rezolve Ai has not officially explained why the page was taken down, the key facts remain confirmed:The partnership is still active. During Rezolve Ai’s Investor Day on October 6, executives specifically highlighted Mastercard as a major distribution partner, alongside Microsoft and Google.The original announcement text is still publicly available. Because regulatory corporate releases are archived by wire services, the unaltered version can still be found on the Nasdaq Press Room for RZLV and on financial platforms such as Yahoo Finance.Companies occasionally remove releases temporarily to fix minor wording issues, coordinate with a partner’s compliance schedule, or wait until a formal statement of work is completed.

$TE — A U.S. SOLAR MANUFACTURING PLAY WITH AN UNEXPECTED AI DATA CENTER ANGLE. ☀️⚡ T1 Energy is building an integrated American solar supply chain — and its latest developments are worth watching. 🔥 Three things investors need to know: 1. AI Data Center Opportunity T1's Giga Arctic facility in Norway has received zoning approval for partial data center redevelopment. The company sees a potential 50 MW facility operating in 2027, with expansion potential. This is an opportunity under development, not yet a completed data center deal. 2. A Major Solar Supply Agreement T1 secured a 641 MW solar module supply agreement with Clearway Energy Group, supporting its strategy to deliver domestically manufactured solar products. 3. Manufacturing Scale-Up Q2 2026 revenue reached $250.1M, with 935 MW of module production. T1 is advancing its G2_Austin solar cell facility, targeting initial cell production in Q1 2027. ⚠️ The risk: T1 still faces execution, capital expenditure and profitability challenges. Q2 net loss from continuing operations was $36.9M. A recent filing also registered up to 7.25M shares held by Evervolt for potential resale. Those shares are not necessarily being sold, and T1 would not receive proceeds from Evervolt's resales.

$CRWV Massive backlog of orders (up to 104 billion US dollars in Backlog): As of the end of the second quarter of 2026, CoreWeave's contracted but unfulfilled revenue (Backlog) has reached an astonishing 104 billion US dollars, and in the beginning of the third quarter, it added over 25 billion US dollars in new customer commitments. The company has secured orders from top AI giants including OpenAI, Microsoft, Meta, and Anthropic. The computing capacity in recent years has been largely "booked" in advance.

$LQDA Liquidia reached a global settlement agreement with its main competitor United Therapeutics (UTHR), completely resolving all outstanding lawsuits and ensuring the continued commercialization of its core drug YUTREPIA.

$ONDS The company announced in July that it had secured a new $70 million defense order, indicating its drones and defense technologies—such as the Mistral-related business it acquired—are gradually transitioning from "story stocks" to established players with substantial military and government contracts. By mid-year, its accumulated backlog had reached several hundred million dollars, and the market is closely watching how well these orders will convert into gross margins and EBITDA in the second half of the year.

$IREN On October 12, 2026, media reported that AI giant Anthropic had finalized a multi-year AI cloud services agreement with IREN. This marks IREN's second major success in securing long-term computing cluster contracts from leading AI labs, following its earlier $9 billion order with Microsoft. The announcement initially drove the company's stock to lead gains among U.S. equities in the computing and new-generation cloud services (Neocloud) sector during after-hours and pre-market trading.

🚀 $AAOI Applied Optoelectronics is becoming a key player in the AI optical infrastructure race. The AI boom is creating a massive bottleneck: Data movement. As hyperscalers build larger AI clusters, demand for high-speed optical connectivity is exploding. AAOI is positioned directly in this trend with its 800G and 1.6T optical transceiver expansion. 🔥 Expanding manufacturing capacity in Texas 🔥 Scaling next-generation 800G/1.6T optical products 🔥 Increasing exposure to AI data center demand The recent strength across optical networking stocks shows investors are recognizing one major theme: AI is not only about GPUs. It is also about the infrastructure that connects them.

$ASTS Elon promises, smoke & mirrors

$IBRX Dr. Patrick posting about talking with NIH in regards to cancer vaccine BEFORE this news broke I think is a very big deal. Add to that and he said we are very close and he needs to obtain clearance to make it public 🫨

$SDST sells its products to electric vehicle (EV) manufacturers ie Tesla as the primary market, with applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs). This has led to increasing demand for the critical minerals used in battery cells, such as lithium, strong governmental incentives for American manufacturing and evolving geopolitical climate that is creating a national security priority for the U.S. market. 20X coming

$HTZ As a reminder > During the Q2 earnings release, management highlighted clear expectations for a Q3 turnaround * Adjusted Corp.EBITDA: Projected to be between $275 and $325 million. * Earnings Per Share (EPS): Expected to return to a positive EPS.

$ONDS European loitering munitions program order: The company announced in early October 2026 a $56 million order for ESADs (electronic safety and arming devices) for the European loitering munitions program, further validating its defense supply chain and product demand.

$JAGX Jaguar Health has successfully reached an amendment to the royalty agreement with Uptown Capital and Streeterville Capital. The previously scheduled monthly repayment plan, set to begin on October 1, 2026, has been deferred to January 1, 2027, and the maturity date of Streeterville's $6.22 million note has also been extended to 2027. This significantly alleviates the company's near-term cash flow pressures and liquidity constraints.

$RZLV Mastercard has been granted the authority to promote and sell the complete software and SaaS subscription of Rezolve AI globally, and is directly responsible for contract signing. This means that Rezolve can directly access the networks of thousands of financial institutions and millions of retailers worldwide operated by Mastercard without having to invest heavily in building a large internal sales team.

$JAGX The company's board of directors announced the distribution of special Series R convertible preferred stock dividends to common shareholders and holders of specific warrants. The record date for the equity registration is October 13, 2026. The official stated that this dividend plan is intended to provide protection against dilution for existing shareholders during the company's assessment of strategic options (such as reorganization, merger, etc.). This has significantly boosted the bullish confidence of retail investors and short-term funds.

$AMOD On October 1, 2026, the company officially received a letter from the Nasdaq Exchange, confirming that it has now regained compliance with the listing regulations of Listing Rule 5550(b)(1), and has temporarily avoided the crisis of being forced to delist. The company has officially completed the private equity initial public offering (PIPE) transaction it previously announced. This transaction was funded by Bitcoin.

$SGRX On September 3, 2026, the company officially changed its name to Sangrix Inc. (with the stock code remaining SGRX), and shifted its business focus from the original cryptocurrency mining and blockchain technology to fully advancing into AI computing infrastructure (including GPU computing, server leasing, storage infrastructure and related services).

$NXL Nexalin Technology (NXL) has officially signed a 10-year international exclusive distribution agreement with Inovanexa. Its neuro-stimulation device (Nexalin Sync™), which is used to treat anxiety, depression and insomnia, has been approved for use in 7 South American countries including Brazil, Algeria and Chile, covering a market of over 300 million people. This marks an important step for the company towards substantive commercialization.